NCT06558084 2024-08-16
Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy
Ain Shams University
Completed
Ain Shams University
Clinical Hospital Center Rijeka
Fudan University
AstraZeneca
Health Outcomes Solutions
National Institutes of Health Clinical Center (CC)